← All organizations

immatics Biotechnologies GmbH

For profitWebsite ↗

Also known as: immatics biotechnolgies GmbH | immatics Biotechnologies GmbH | Immatics US, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 25, 2025

Timeline

2000s

Jan 1, 2000
immatics Biotechnologies GmbH— Founded

Drugs by trial phase (31 distinct, 18 trials)

Phase 3 (14 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (10 own, 0 via acquisition)

Indications

Studied for

Recent trials (27)

NCT06946225Lead sponsorPhase 1Jul 25, 2025
NCT06743126OfficialPhase 3Dec 31, 2024
NCT06743126Lead sponsorPhase 3Dec 31, 2024
NCT05958121Lead sponsorPhase 1/Phase 2Aug 9, 2023
NCT05958121Study directorPhase 1/Phase 2Aug 9, 2023
NCT05359445Study directorPhase 1May 19, 2022
NCT05359445Lead sponsorPhase 1May 19, 2022
NCT05359445OfficialPhase 1May 19, 2022
NCT03441100Study directorPhase 1May 2, 2019
NCT03441100Lead sponsorPhase 1May 2, 2019
NCT03686124Lead sponsorPhase 1Mar 31, 2019
NCT03318900CollaboratorPhase 1Jul 16, 2018
NCT03247309Lead sponsorPhase 1Sep 26, 2017
NCT03247309Study directorPhase 1Sep 26, 2017
NCT03203005CollaboratorPhase 1/Phase 2Sep 18, 2017

Details

Founded: Tübingen, DE Jan 1, 2000
Last known activity: Jul 25, 2025